Literature DB >> 17397969

The mitochondrial permeability transition in neurologic disease.

M D Norenberg1, K V Rama Rao.   

Abstract

Mitochondria, being the principal source of cellular energy, are vital for cell life. Yet, ironically, they are also major mediators of cell death, either by necrosis or apoptosis. One means by which these adverse effects occur is through the mitochondrial permeability transition (mPT) whereby the inner mitochondrial membrane suddenly becomes excessively permeable to ions and other solutes, resulting in a collapse of the inner membrane potential, ultimately leading to energy failure and cell necrosis. The mPT may also bring about the release of various factors known to cause apoptotic cell death. The principal factors leading to the mPT are elevated levels of intracellular Ca2+ and oxidative stress. Characteristically, the mPT is inhibited by cyclosporin A. This article will briefly discuss the concept of the mPT, its molecular composition, its inducers and regulators, agents that influence its activity and describe the consequences of its induction. Lastly, we will review its potential contribution to acute neurological disorders, including ischemia, trauma, and toxic-metabolic conditions, as well as its role in chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397969      PMCID: PMC4714712          DOI: 10.1016/j.neuint.2007.02.008

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  222 in total

Review 1.  Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.

Authors:  J P Julien
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  The role of creatine kinase in inhibition of mitochondrial permeability transition.

Authors:  E O'Gorman; G Beutner; M Dolder; A P Koretsky; D Brdiczka; T Wallimann
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

4.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

5.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

6.  Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.

Authors:  J K Parks; T S Smith; P A Trimmer; J P Bennett; W D Parker
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

7.  Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain.

Authors:  E O'Gorman; G Beutner; T Wallimann; D Brdiczka
Journal:  Biochim Biophys Acta       Date:  1996-09-12

8.  Manganese induces the mitochondrial permeability transition in cultured astrocytes.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

Review 9.  Mitochondrial degeneration in amyotrophic lateral sclerosis.

Authors:  Zuoshang Xu; Cheowha Jung; Cynthia Higgins; John Levine; Jiming Kong
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

View more
  59 in total

1.  Modulation of methylmercury uptake by methionine: prevention of mitochondrial dysfunction in rat liver slices by a mimicry mechanism.

Authors:  Daniel Henrique Roos; Robson Luiz Puntel; Marcelo Farina; Michael Aschner; Denise Bohrer; João Batista T Rocha; Nilda B de Vargas Barbosa
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-27       Impact factor: 4.219

Review 2.  Bioenergetics and cell death.

Authors:  Yulia Kushnareva; Donald D Newmeyer
Journal:  Ann N Y Acad Sci       Date:  2010-07       Impact factor: 5.691

Review 3.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

Review 4.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 5.  Signaling factors in the mechanism of ammonia neurotoxicity.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

6.  Prospective study of chemical exposures and amyotrophic lateral sclerosis.

Authors:  M G Weisskopf; N Morozova; E J O'Reilly; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

Review 7.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

Review 9.  Mitochondrial calcium function and dysfunction in the central nervous system.

Authors:  David G Nicholls
Journal:  Biochim Biophys Acta       Date:  2009-03-17

10.  Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Authors:  Natalie E Scholpa; Hannah Williams; Wenxue Wang; Daniel Corum; Aarti Narang; Stephen Tomlinson; Patrick G Sullivan; Alexander G Rabchevsky; Rick G Schnellmann
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.